DEF: Alchemy Investments Acquisition Corp. Seeks Shareholder Vote for Business Combination Extension

Alchemy Investments Acquisition Corp. is holding its annual general meeting on September 1, 2026, to vote on extending the deadline to complete its proposed business combination with Cartiga, LLC.

Summary

• Alchemy Investments Acquisition Corp. (ALCY) is holding its annual general meeting on September 1, 2026, to seek shareholder approval for an extension to complete its proposed business combination with Cartiga, LLC.
• The company is requesting to extend the deadline from September 9, 2026, to September 9, 2027, on a month-to-month basis, to allow more time for the business combination to be finalized.
• Shareholders will also vote on ratifying the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and on a proposal to adjourn the meeting if necessary.
• The sponsor, Alchemy DeepTech Capital LLC, has agreed to provide loan contributions to fund the extension periods, up to September 9, 2027, if the Extension Proposal is approved.
• ALCY's securities were suspended from trading on Nasdaq on May 14, 2026, due to non-compliance with listing rules regarding the completion of a business combination within 36 months of its IPO effectiveness, and are now trading on OTC Markets.
• Shareholders have the right to redeem their Class A ordinary shares in connection with the vote on the Extension Proposal.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the delisting from Nasdaq, the need for an extension, and the potential for liquidation if the business combination is not completed.

Positives

• The Extension Proposal provides additional time for ALCY to complete its business combination, potentially leading to a successful merger and future growth.
• The sponsor has committed to providing financial support through loans to fund the extension periods, demonstrating continued commitment to the transaction.
• Shareholders retain the right to vote on the business combination and to redeem their shares if they choose not to proceed with the merger.
• The company is seeking to ratify its auditor, ensuring continued financial oversight and compliance.

Negatives

• ALCY's securities have been delisted from Nasdaq and are now trading on OTC Markets, indicating a significant reduction in liquidity and market visibility.
• The company has already extended its deadline multiple times, suggesting potential difficulties in finalizing a business combination.
• If the business combination is not completed by the extended date, the company will cease operations and liquidate, resulting in shareholders losing their investment.
• The trust account balance has significantly decreased due to redemptions, impacting the potential return for remaining shareholders.

Risks

• Failure to complete the business combination by the extended date will result in the company ceasing operations and liquidating, causing shareholders to lose their investment.
• The company's securities are no longer trading on Nasdaq and are subject to delisting, which could impact liquidity and investor confidence.
• There is a risk that the company could be deemed an investment company under the Investment Company Act of 1940, forcing it to liquidate.
• The business combination may be subject to review by CFIUS, which could delay or block the transaction.
• Shareholders who do not redeem their shares may be liable for creditor claims in the event of an insolvent liquidation.
• The trust account balance has decreased significantly due to redemptions, potentially impacting the per-share redemption value.

Future Outlook

The company is seeking an extension until September 9, 2027, to complete its business combination. If approved, it will continue to pursue the combination or an alternative. If not approved, the company will liquidate.

Management Comments

• The ALCY Board has determined that the Business Combination and the transactions contemplated thereby are fair to and in the best interests of ALCY and its shareholders because they believe that Cartiga is a company with strong revenue growth potential.
• The ALCY Board believes that Cartiga has demonstrated a good return on investment capital for its client base.
• Cartiga has a business plan dedicated to both near term cash flow and long term growth.
• The Board believes shareholders will benefit from the Company's consummating the Proposed Business Combination and is proposing the Extension Proposal to extend the date by which the Company has to complete the Proposed Business Combination.
• The Board recommends that shareholders vote FOR the Extension Proposal, FOR the Ratification of Auditors Proposal and FOR the Adjournment Proposal.

Industry Context

StockSavvy.ai notes that this filing reflects a common challenge faced by Special Purpose Acquisition Companies (SPACs) in the current market environment, where extensions are often necessary due to delays in completing business combinations and increased regulatory scrutiny, such as Nasdaq delisting concerns.

Comparison to Industry Standards

• Many SPACs have sought and received extensions to complete their initial business combinations, indicating a trend of longer timelines in the current market.
• The delisting from Nasdaq and subsequent trading on OTC markets is a negative indicator compared to SPACs that maintain their primary exchange listing.
• The structure of the proposed business combination, utilizing an Up-C structure, is a common strategy for private companies seeking to go public while allowing existing equity holders to retain their ownership in the operating entity and benefit from potential tax advantages.

Legal Proceedings

• ALCY received a notice from Nasdaq on April 7, 2026, stating non-compliance with IM-5101-2, leading to suspension from trading on May 14, 2026.

Related Party Transactions

• The sponsor, Alchemy DeepTech Capital LLC, has agreed to provide loan contributions to fund the extension periods.
• The sponsor and initial shareholders have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares.
• The sponsor and initial shareholders have agreed to vote their shares in favor of the Extension Proposal and any business combination.

Stakeholder Impact

• Public shareholders face the risk of losing their investment if the business combination is not completed and the company liquidates.
• Shareholders who redeem their shares will receive a pro rata portion of the trust account, which may be less than their initial investment.
• The delisting from Nasdaq and trading on OTC markets reduces liquidity for all shareholders.
• The sponsor and initial shareholders risk their founder shares and private warrants becoming worthless if the business combination fails.

Next Steps

• Shareholders will vote on the Extension Proposal, Ratification of Auditors Proposal, and Adjournment Proposal at the General Meeting on September 1, 2026.
• If the Extension Proposal is approved, the company will continue to pursue the business combination until September 9, 2027.
• If the Extension Proposal is not approved, the company will cease operations and begin liquidation procedures.
• If the Extension Proposal is approved, the sponsor will provide loan contributions to fund the extension periods.

Key Dates

Recommendation

The company is in a precarious position with delisting from Nasdaq and a pending extension vote. While the proposed business combination with Cartiga, LLC is viewed positively by management, the significant delays and risks associated with completing the transaction warrant a cautious 'hold' recommendation. Investors should monitor the outcome of the shareholder vote and any further developments regarding the business combination.

Keywords

Special Purpose Acquisition Company, SPAC, Business Combination, Extension Proposal, Shareholder Meeting, Redemption Rights, Delisting, Cartiga LLC